x

Search for an orphan drug

* (*) mandatory field

Other search option(s)

Orphan designation - USA

  • Substance: Autologous engineered anti -CD19 Chimeric Antigen Receptor (CAR +) T -cells
  • ATC code : -
  • EU Number: -
  • Designation date : 14/03/2014
  • Sponsor of orphan designation : NOVARTIS PHARMACEUTICAL CORPORATION

Designation

Treatment of chronic lymphocytic leukemia.

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.